Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | 0.00% | 0.00% | 0.00% |
26/01 | Optimind Pharma Reaches Agreement On Debenture Conversion | MT |
10/01 | Optimind Pharma Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2023 | CI |
Quotes 5-day view
Delayed Quote Canadian Securities Exchange14/05/2024 | |
---|---|
Last | 0.005 $ |
Volume | 20 000 |
Change | +∞% |
Opening | 0.01 |
High | 0.01 |
Low | 0.01 |
Performance
6 months | -50.00% | ||
1 year | -80.00% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
0.00% | 0.00% | 0.00% | -80.00% | 4L | ||
+1.04% | +5.31% | +9.42% | +30.29% | 11TCr | ||
+1.48% | +0.87% | +11.84% | +29.41% | 11TCr | ||
-1.71% | -2.37% | -2.74% | -14.40% | 2.2TCr | ||
-2.55% | -1.16% | -14.15% | -14.91% | 2.19TCr | ||
+0.74% | +1.90% | -5.29% | -27.68% | 1.92TCr | ||
+1.06% | +7.27% | -4.16% | -25.69% | 1.81TCr | ||
-1.49% | +0.11% | -38.29% | -33.18% | 1.77TCr | ||
+0.27% | +4.09% | +7.99% | +51.28% | 1.43TCr | ||
-1.02% | -0.33% | +36.24% | -11.88% | 1.24TCr | ||
-2.61% | +4.44% | -24.95% | -35.24% | 823.19Cr | ||
-1.17% | +14.39% | +18.74% | +54.61% | 811.29Cr | ||
-0.59% | -0.21% | -0.71% | +29.70% | 767.04Cr | ||
-0.14% | -0.71% | -52.57% | -68.48% | 749.37Cr | ||
-3.03% | -9.02% | +260.02% | +191.68% | 738.8Cr | ||
-1.37% | -9.25% | -3.83% | +34.00% | 694.56Cr | ||
Average | -0.40% | +0.57% | +12.35% | +6.84% | ||
Weighted average by Cap. | -0.05% | +2.01% | +7.95% | +16.51% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | 0.00% | ||
2023 | -83.33% | ||
2022 | -80.00% |
- Stock Market
- Equities
- OMND Stock
- Quotes Optimind Pharma Corp.